scPharmaceuticals

money bills fundraise

Pharma

ScPharmaceuticals raises $50M for launch of on-body infusor

ScPharmaceuticals priced a $50 million public offering ahead of the planned launch of the self-administered heart failure therapy early next year.

Nick Paul Taylor Nov 22, 2022 10:40am

heart failure

FDA signs off on scPharmaceutical’s on-body infusor for HF

Oct 10, 2022 10:51am

FDA

ScPharmaceuticals gets decision date for twice-rejected therapy

May 17, 2022 9:40am

FDA Building 2

ScPharmaceuticals plots refiling of twice-rejected therapy

Mar 2, 2021 7:20am